Gas-phase hydrogen/deuterium exchange of D 2 O with [M+H] + ions of angiotensin II, angiotensin I, [Sar 1 ]-angiotensin II, bradykinin, des-Arg 1 -bradykinin, des-Arg 9 -bradykinin, luteinizing hormone releasing hormone (LH-RH), and substance P has been examined by Fourier transform ion cyclotron resonance mass spectrometry at 9.4 tesla. Because the FTICR dynamic range increases quadratically with magnetic field, parent ions from a mixture of several peptides may be confined simultaneously for long periods at high pressure (e. g., 1 h at 1×10 −5 torr) without quadrupolar axialization (and its attendant ion heating), for faster data acquisition and better controlled comparisons between different peptides. A high magnetic field also facilitates stored waveform inverse Fourier transform (SWIFT) isolation of monoisotopic [M+H] + parent ions, so that deuterium incorporation patterns may be determined directly without the need for isotopic distribution deconvolution. Finally, a higher magnetic field provides for a greatly extending trapping period, for measurement of much slower rates. Angiotensin I, angiotensin II, and [Sar 1 ]-angiotensin II are found to undergo a rapid exchange. Angiotensin II and [Sar 1 ]-angiotensin II exhibit multiple deuterium uptake distributions, corresponding to multiple gas-phase conformations. In contrast, substance P exchanges slowly and LH-RH displays no observable exchange. Comparison of the relative H/D exchange rates for bradykinin and its des-Arg-derivatives supports the hypothesis that bradykinin adopts a folded gas-phase conformation that unfolds upon removal of either terminal arginine residue.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: